Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Dr Reddys Laboratories (RDY) over the last 6 years, with Q3 2025 value amounting to $590.9 million.

  • Dr Reddys Laboratories' Change in Acquisitions & Divestments fell 5723.5% to $590.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 2752.62%. This contributed to the annual value of $1.4 billion for FY2023, which is 3466.51% up from last year.
  • As of Q3 2025, Dr Reddys Laboratories' Change in Acquisitions & Divestments stood at $590.9 million, which was down 5723.5% from $487.7 million recorded in Q2 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Change in Acquisitions & Divestments peaked at $1.4 billion during Q3 2024, and registered a low of $487.7 million during Q2 2025.